Original Research

Comparison of erlotinib and pemetrexed as second-/third-line treatment for lung adenocarcinoma patients with asymptomatic brain metastases

He YY, Sun WW, Wang Y, Ren SX, Li XF, Li JY, Rivard CJ, Zhou CC, Hirsch FR

OncoTargets and Therapy 2016, 9:2409-2414

Published Date: 21 April 2016